TW201141542A - Functional double-effect powder packet - Google Patents

Functional double-effect powder packet Download PDF

Info

Publication number
TW201141542A
TW201141542A TW99117159A TW99117159A TW201141542A TW 201141542 A TW201141542 A TW 201141542A TW 99117159 A TW99117159 A TW 99117159A TW 99117159 A TW99117159 A TW 99117159A TW 201141542 A TW201141542 A TW 201141542A
Authority
TW
Taiwan
Prior art keywords
functional double
effect powder
powder package
effect
double
Prior art date
Application number
TW99117159A
Other languages
Chinese (zh)
Inventor
Hong-Lin Chen
Original Assignee
Tci Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tci Co Ltd filed Critical Tci Co Ltd
Priority to TW99117159A priority Critical patent/TW201141542A/en
Publication of TW201141542A publication Critical patent/TW201141542A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention discloses a functional double-effect powder package, of which the contents include fine particles and powder, wherein the partitioned absorption effect is utilized to increase the body's absorption rate, and the powder packet contents can also be in the form of capsules or tablets as health food or pharmaceuticals.

Description

201141542 六、發明說明: 【發明所屬之技術領域】 本發明是有關於一種機能性雙效粉包,特別是有 關於其内容物粉末及微粒可以分區釋放吸收以增加身 體吸收率。 【先前技術】201141542 VI. Description of the Invention: [Technical Field] The present invention relates to a functional double-effect powder package, and particularly relates to a powder and a microparticle thereof which can be released and absorbed in a partition to increase the body absorption rate. [Prior Art]

、市售健康食品或醫藥品’許多效性成份之釋放區 域没計錯誤,造成效性成份失效或吸收不良,使身體 吸收率大大降低,產品效果大打折扣。 部份營養素及效性成份經過胃部的酸性環境,〜 因胃酸之分解作用導致效性減低或失效,以致二二 吸收率非常低。 、牙體 而部份營養素及效性成份會受胃酸分解破壞,3 由於缺乏有效地保護,無法通過胃酸之考驗, ^ 道吸收率下降,對人體之功效更是微乎其微。 人體 凋化糸統並非母個部位皆能吸收 或效性成份’有區域性之分別,而效性成二^ =放區域料錯誤造成效性成份或營養素無“= =鑑於習知技藝之各項問題’為 之’本發明人基於多年研究開發與諸多=解決 :-種機能性雙效粉包,其包含一微二提 作為改善上述缺點之實現方式與依據。 q末,以 201141542 【發明内容】 有鑑於此,本發明之目的就是在提供一種機能性 雙效粉包,纟包含-微粒及一粉末,此機能性雙效粉 包所含之粉末及微粒,係藉由分區釋放吸收以掸 體吸收率。 9豸 根據本發明之目的,提出一種機能性雙效粉包, 其包含一微粒及一粉末。 此外,本發明之機能性雙效粉包,其包含之微粒 係於腸道吸收釋放。 本發明之機能性雙效粉包,其包含之粉末係於 部吸收釋放。 ' 而其機能性雙效粉包,該微粒係由一糖蕊、一效 性成份及一膜衣。 > 此外’本發明之微粒之製造方法,其至少包含 列步驟: 步驟1:提供一效性成份,並與其他造粒成份及 水份一併混合’即為糖蕊團; 步驟2 :將混合好之糖蕊團以擠壓搓圓之方式製 成糖蕊;及 步驟3:將製成完畢之糖蕊烘乾後噴上膜衣即完 成微粒部份。 該微粒由於有膜衣保護,能夠有效保護效性成份 順利通過胃酸。 其中其微粒及粉末為不同之效性成份,可直接增 201141542 加產品訴求。 承上所述,因依本發明之機能性雙效拾 含一微粒及一粉末,具有以下優點: ’ ^ (1) 機能性雙效粉包,其粉末及微粒分區釋玫, 有效提升身體吸收率。 又% (2) 此機能性雙效粉包之内容物還可以以膠 劑之形式做為健康食品或醫藥品。 乂Commercially available health foods or pharmaceuticals. The release areas of many effective ingredients are not mistaken, resulting in failure or malabsorption of the active ingredients, which greatly reduces the body's absorption rate and greatly reduces the product's effectiveness. Some nutrients and effective ingredients pass through the acidic environment of the stomach. ~ The effect of gastric acid decomposition leads to reduced or no effect, so that the absorption rate is very low. The tooth and some nutrients and effective ingredients will be destroyed by the decomposition of gastric acid. 3 Due to the lack of effective protection, it cannot pass the test of stomach acid. The absorption rate of the channel decreases, and the effect on the human body is minimal. Human body littering is not a part of the parent can absorb or have the effect of the composition of the 'regional difference, and the effect of the two ^ = area material error caused by effective ingredients or nutrients no == = given the various skills The problem of 'for this' is based on years of research and development and many = solution: a kind of functional double-effect powder package, which contains a micro-two mention as an implementation and basis for improving the above shortcomings. qEnd, to 201141542 In view of the above, the object of the present invention is to provide a functional double-effect powder package comprising: - particles and a powder, the powder and particles contained in the functional double-effect powder package are released by partition absorption Carcass absorption rate. According to the object of the present invention, a functional double-effect powder package comprising a microparticle and a powder is provided. Further, the functional double-effect powder package of the present invention contains microparticles in the intestinal tract. Absorptive release. The functional double-effect powder package of the present invention comprises a powder which is absorbed and released in the part. The functional double-effect powder package is composed of a sugar core, a primary ingredient and a film coat. > The method for producing microparticles of the present invention comprises at least the following steps: Step 1: providing an effective ingredient and mixing it with other granulating ingredients and water 'is a sugar core; Step 2: mixing the sugar The core group is made into a sugar core by extrusion and rounding; and step 3: drying the finished sugar core and spraying the film coat to complete the particle portion. The particle is effectively protected by the film coating protection. The sexual components pass through the stomach acid smoothly. Among them, the microparticles and powders are different effective ingredients, which can directly increase the 201141542 plus product appeal. According to the above, the functional double effect pick-up contains a particle and a powder, and has the following Advantages: ' ^ (1) Functional double-effect powder package, its powder and microparticle partition release, effectively improve the body absorption rate. Also % (2) The content of this functional double-effect powder package can also be in the form of glue As a health food or pharmaceutical. 乂

【實施方式】 本發明人經過廣泛而深入的研究和實驗, 到一種機能性雙效粉包,其包含一微粒及一粉末了 = 種試驗表明,所述的機能性雙效粉包可增加^性二 在人體之身體吸收率,基於此本發明得以完成。刀 依本發明之機能性雙效粉包,其粉末部份之效性 成份係以能在胃部吸收作用之效性成份為主,如水溶 $維生素或某些能於胃部吸收作用之藥物或效性成 而該微粒部份之效性成份係以腸道吸收作用之效 性成份為主,由於該效性成份有膜衣之保 性成份通過胃酸環境,進而降低效性成份被胃 -夂刀解’增加人體之效性成份吸收率。 其中該微粒包含-糖蕊、—效性成份及一膜衣, 而該微粒之製造方法至少包含下列步驟: 步驟一:提供一效性成份,並與其他造粒成份及水 份一併混合,即為糖蕊團; 201141542 步驟二 步驟三 合1之糖蕊團以擠壓搓圓之方式製成 將製成完畢之糖蕊烘乾後噴上 ^^粒部份。 m 衣即完成 其中該擠壓搓圓之糖蕊製作方式,先 =成成份加入定量之水份,混合均句成=二所 經細孔儀器之擠壓形成細條狀,等長截斷後再 等粒徑搓圓,將搓圓完畢之微粒供乾後即為微[Embodiment] The inventors have conducted extensive and intensive research and experiments to a functional double-effect powder package containing a microparticle and a powder. The test shows that the functional double-effect powder package can be increased by ^ The absorption rate of sex in the body of the human body is based on the present invention. According to the functional double-effect powder package of the present invention, the powder component is mainly composed of an effective ingredient which can be absorbed in the stomach, such as water-soluble vitamins or certain drugs which can be absorbed in the stomach. Or the effect is that the effective component of the microparticle part is mainly the effective component of intestinal absorption, because the protective component has the protective component of the film coating through the stomach acid environment, thereby reducing the effectiveness of the ingredient by the stomach - The sickle solution 'increased the absorption rate of the body's effective ingredients. Wherein the microparticle comprises a sugar core, an effect component and a film coating, and the method for producing the microparticle comprises at least the following steps: Step 1: providing an effective ingredient and mixing it with other granulating ingredients and water. That is, the sugar core group; 201141542 Step 2 Steps The three-in-one sugar core group is formed by extruding the rounded sugar, and the finished sugar core is dried and sprayed with the ^^ grain portion. m clothing is completed in the extrusion of the rounded sugar core production method, first = into the ingredients to add a certain amount of water, mixed into the sentence = two by the fine hole instrument extrusion to form a thin strip, after the same length cut off and so on The particle size is round, and the microparticles after the rounding is dried

能性雙效粉 而該烘乾完成之微粒噴上膜衣即為機 包之微粒完成品。 取300毫克之維生素c粉末及25〇毫克之 B12粉末均勻混合後即為雙效粉包之粉末部份。、 取300毫克之膠原蛋白粉末、1〇〇毫克乳糖粉末、 50毫克之微結晶纖維素、5〇毫克之麥芽糊精及毫 克之二氧化鈦,均勻混合後加入1〇毫克水份,擠壓搓 圓後烘乾,喷上膜衣即為機能性雙效粉包之微粒部份。 將上述之粉末與微粒混合後包裝及為機能性雙效 粉包。 依本發明之雙效粉包,其更包含兩種以上之效性 成份,其内容物也可以以膠囊或錠劑之形式做為健康 食品或醫藥品。 ' 本發明僅對上述實施例加以詳細說明,但熟悉該 項技術者應可明白,在本發明的技術思想範圍内可作 多樣的變形及修飾’該變形及修飾當然包含申請專利 201141542 範圍内。 【圖式簡單說明】 無The double-effect powder of the energy and the fine film sprayed on the dried film are the finished products of the package. The powder portion of the double-effect powder package is obtained by uniformly mixing 300 mg of vitamin C powder and 25 mg of B12 powder. Take 300 mg of collagen powder, 1 mg of lactose powder, 50 mg of microcrystalline cellulose, 5 mg of maltodextrin and mg of titanium dioxide, mix uniformly, add 1 mg of water, squeeze 搓After rounding, the film coat is the particle part of the functional double-effect powder package. The above powder and the fine particles are mixed and packaged and used as a functional double-effect powder package. According to the double-effect powder package of the present invention, it further comprises two or more kinds of effective ingredients, and the contents thereof can also be used as a health food or a medicine in the form of a capsule or a lozenge. The present invention is only described in detail with reference to the above-described embodiments, but it should be understood by those skilled in the art that various modifications and changes can be made within the scope of the technical idea of the present invention. The modifications and modifications of course include the scope of the patent application 201141542. [Simple description of the diagram]

【主要元件符號說明】 無[Main component symbol description] None

Claims (1)

201141542 七、申5青專利範圍: 1. 一種機能性雙效粉包,其組成包含一微粒及一粉末。 2. 如申請專利範圍第1項所述之機能性雙效粉包,其微 粒係於腸道釋放吸收。 3. 如申請專利範圍第1項所述之機能性雙效粉包,其粉 末係於胃部釋放吸收。 4. 如申請專利範圍第2項至第3項所述之機能性雙效粉 包’其分區吸收之目的係用以增加身體吸收率。 5. 如申請專利範圍第2項所述之機能性雙效粉包,其微 粒包含一糖蕊、一效性成份及一膜衣。 6. 如申請專利範圍第5項所述之機能性雙效粉包,其膜 衣可有效保護微粒之效性成份通過胃酸環境到達腸道 釋放吸收。 7. 如申請專利範圍第1項所述之機能性雙效粉包,其微 粒及粉末為不同之效性成份。 8. 如申請專利範圍第2項所述之機能性雙效粉包,其料 粒之製作過程包含下列步驟: ' 提供一效性成份,並與其他造粒成份及水份一併混 合,即為糖蕊團; 將混合好之糖蕊團以擠壓搓圓之方式製成糖蕊;及 將製成完畢之糖蕊烘乾後喷上膜衣即完成微粒部份。 9. 如申請專利範圍第1項所述之機能性雙效粉包,其雙 效粉包之内容物也可以以膠囊或錠劑之型式作為 品及健康食品。 μ201141542 VII, Shen 5 Qing patent scope: 1. A functional double-effect powder package, the composition of which comprises a particle and a powder. 2. For the functional double-effect powder package described in the first paragraph of the patent application, the micro-granules are released in the intestinal tract. 3. If the functional double-effect powder package described in the first paragraph of the patent application is applied, the powder is released and absorbed in the stomach. 4. The functional double-effect powder package as described in items 2 to 3 of the patent application is intended to increase the body absorption rate. 5. The functional double-effect powder package of claim 2, wherein the microparticles comprise a sugar core, a primary ingredient and a film coat. 6. If the functional double-effect powder package described in claim 5 is applied, the film coating can effectively protect the particulate active ingredient from reaching the intestinal tract through the gastric acid environment and releasing and absorbing. 7. For the functional double-effect powder package described in the scope of patent application, the micro-particles and powders are different effective ingredients. 8. In the functional double-effect powder package described in claim 2, the process of preparing the pellet comprises the following steps: 'providing a first-acting ingredient and mixing it with other granulating ingredients and water, ie It is a sugar core group; the mixed sugar core group is made into a sugar core by extrusion and rounding; and the finished sugar core is dried and sprayed on the film coat to complete the particle portion. 9. If the functional double-effect powder package described in claim 1 is applied, the contents of the double-effect powder package may also be in the form of a capsule or a lozenge as a health food. μ
TW99117159A 2010-05-28 2010-05-28 Functional double-effect powder packet TW201141542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99117159A TW201141542A (en) 2010-05-28 2010-05-28 Functional double-effect powder packet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99117159A TW201141542A (en) 2010-05-28 2010-05-28 Functional double-effect powder packet

Publications (1)

Publication Number Publication Date
TW201141542A true TW201141542A (en) 2011-12-01

Family

ID=46764744

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99117159A TW201141542A (en) 2010-05-28 2010-05-28 Functional double-effect powder packet

Country Status (1)

Country Link
TW (1) TW201141542A (en)

Similar Documents

Publication Publication Date Title
AU2006319077B2 (en) Slow-release composition, method for the preparation thereof, and use of the same
US10512650B2 (en) Layered sustained-release microbeads and methods of making the same
JP2016511271A (en) Oral nutrition and pharmaceutical composition for veterinary medicine
US11872316B2 (en) Delivery system
US20210228492A1 (en) Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form
CN106619565B (en) Arginine preparation, and preparation method and application thereof
TW201141542A (en) Functional double-effect powder packet
CN101658482A (en) Low molecular chondroitin sulfate oral preparation, preparation method thereof and use thereof
JP6004702B2 (en) Method for producing solid preparation with reduced unpleasant taste
KR102549896B1 (en) Capsule containing pyrroloquinolinequinone or a salt thereof and branched-chain amino acids
WO2020221574A1 (en) New delivery system for specific water-soluble vitamins
CN103816123A (en) Cefuroxime axetil composition and preparation method thereof
CN103127000A (en) Isosorbide mononitrate chronopharmacological sustained release pellet drug delivery system and its preparation method
EP1949900A3 (en) Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof
US10213453B2 (en) Control release of fat soluble antioxidants from an oral formulation and method
TWM629347U (en) Composite grain structure containing superoxide dismutase
EP3962461A1 (en) New delivery system for fat soluble vitamins
TWM624636U (en) Structure of micro-complex with ingredients and yeast
JP6910962B2 (en) Aqueous enteric coating composition
TW201215413A (en) Particle technology for improving absorption
KR20210079315A (en) Lipid composition for encapsulating an active substance, allowing control of the release rate of the active substance
TW201141543A (en) Dosage beverage of sustained-release fine particles
TW201136616A (en) Enteric-coated sustained-release particle
TW201204743A (en) Glucosamine drink powder
RO130316A2 (en) Combined oral formulation for controlled release of acetylsalicylic acid and process for preparing the same